DarioHealth

Personalized, pocket-sized, all-in-one glucose meter coupled with a robust real time mobile app to manage diabetes quickly, efficiently and accurately.

Launch date

2011

Employees

201-500 people

Market cap

Net debt

Enterprise valuation

$39m (Public information from Jul 2024)

New York City New York (HQ), Hof HaCarmel Regional Council Haifa District (founding location)

http://mydario.com

https://twitter.com/dariohealth https://www.facebook.com/darioglucometerforsmartphone https://www.linkedin.com/company/dariohealth/https://apps.apple.com/app/id571322125 https://play.google.com/store/apps/details?id=com.labstyle.darioandroid

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	7.6m	20.5m	27.7m	20.4m	37.3m	49.7m	73.7m
% growth	-	171 %	35 %	(26 %)	83 %	33 %	48 %
EBITDA	(30.2m)	(73.0m)	(52.4m)	(50.0m)	(30.0m)	(9.8m)	14.2m
% EBITDA margin	(398 %)	(356 %)	(189 %)	(246 %)	(80 %)	(20 %)	19 %
Profit	(29.4m)	(76.8m)	(62.2m)	(59.4m)	(61.3m)	(42.3m)	(20.8m)
% profit margin	(389 %)	(374 %)	(225 %)	(292 %)	(164 %)	(85 %)	(28 %)
EV / revenue	15.3x	10.5x	4.0x	2.3x	1.1x	0.8x	0.6x
EV / EBITDA	-3.9x	-3.0x	-2.1x	-0.9x	-1.4x	-4.3x	3.0x
R&D budget	4.4m	17.2m	19.6m	20.2m	-	-	-
R&D % of revenue	59 %	84 %	71 %	99 %	-	-	-

Date	Investors	Amount	Round
-	OurCrowd Phoenix Insurance Company	N/A	-
Dec 2019	N/A	$21.3m	Post IPO Equity
Jul 2020	N/A	$28.6m	Post IPO Equity
Jan 2021	Farallon Capital Management Pura Vida Investments Nantahala Capital Management	$70.0m	Private Placement VC
May 2023*	N/A	$14.3m	Post IPO Convertible
May 2023*	Avenue Capital Group	$30.0m	Post IPO Debt
Total Funding		$92.3m